JP2024517204A5 - - Google Patents
Info
- Publication number
- JP2024517204A5 JP2024517204A5 JP2023567060A JP2023567060A JP2024517204A5 JP 2024517204 A5 JP2024517204 A5 JP 2024517204A5 JP 2023567060 A JP2023567060 A JP 2023567060A JP 2023567060 A JP2023567060 A JP 2023567060A JP 2024517204 A5 JP2024517204 A5 JP 2024517204A5
- Authority
- JP
- Japan
- Prior art keywords
- octreotide
- composition according
- patient
- composition
- plasma concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE2130118-9 | 2021-05-04 | ||
| SE2130118 | 2021-05-04 | ||
| PCT/SE2022/050404 WO2022235186A1 (en) | 2021-05-04 | 2022-04-26 | Compositions and methods for treating neuroendocrine tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517204A JP2024517204A (ja) | 2024-04-19 |
| JP2024517204A5 true JP2024517204A5 (https=) | 2025-05-07 |
Family
ID=83932120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567060A Pending JP2024517204A (ja) | 2021-05-04 | 2022-04-26 | 神経内分泌腫瘍を治療するための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250281569A1 (https=) |
| EP (1) | EP4333874A4 (https=) |
| JP (1) | JP2024517204A (https=) |
| KR (1) | KR20240004706A (https=) |
| CN (1) | CN117241822A (https=) |
| AU (1) | AU2022271139A1 (https=) |
| CA (1) | CA3217408A1 (https=) |
| IL (1) | IL308133A (https=) |
| MX (1) | MX2023013060A (https=) |
| WO (1) | WO2022235186A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4731247A1 (en) * | 2023-06-20 | 2026-04-29 | Camurus AB | Compositions and methods for treating acromegaly |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103702662B (zh) * | 2011-05-25 | 2018-07-20 | 卡穆鲁斯公司 | 控制释放肽制剂 |
| GB201402423D0 (en) * | 2014-02-12 | 2014-03-26 | New Injection Systems Ltd | Auto-injector assembly |
| MX383392B (es) * | 2016-09-27 | 2025-03-13 | Camurus Ab | Mezclas y formulaciones que comprenden una sal de alquil amonio de ácido etilendiaminotetraacético (edta). |
| WO2020240018A1 (en) * | 2019-05-29 | 2020-12-03 | Camurus Ab | Administration device & regime |
-
2022
- 2022-04-26 IL IL308133A patent/IL308133A/en unknown
- 2022-04-26 JP JP2023567060A patent/JP2024517204A/ja active Pending
- 2022-04-26 CA CA3217408A patent/CA3217408A1/en active Pending
- 2022-04-26 AU AU2022271139A patent/AU2022271139A1/en active Pending
- 2022-04-26 US US18/558,623 patent/US20250281569A1/en active Pending
- 2022-04-26 WO PCT/SE2022/050404 patent/WO2022235186A1/en not_active Ceased
- 2022-04-26 KR KR1020237041028A patent/KR20240004706A/ko active Pending
- 2022-04-26 CN CN202280032371.0A patent/CN117241822A/zh active Pending
- 2022-04-26 EP EP22799203.9A patent/EP4333874A4/en active Pending
- 2022-04-26 MX MX2023013060A patent/MX2023013060A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2200171T3 (es) | Combinaciones de vasopresina y agentes adrenergeticos para el tratamiento del paro cardiaco. | |
| CN102883722B (zh) | 用于肺动脉高血压的治疗 | |
| JP6422855B2 (ja) | インスリンおよびインスリン類似体の薬物動態及び薬力学、ならびに注射部位の疼痛を調節するためのマグネシウム組成物 | |
| JP2015512392A5 (https=) | ||
| JP2014088444A5 (https=) | ||
| JP2004059590A (ja) | リポソームに封入されたタキサンの投与方法 | |
| JP2014524480A5 (https=) | ||
| BR112013005907B1 (pt) | Composição farmacêutica parenteral | |
| CA2805031A1 (en) | Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of insulin | |
| JP2025118607A5 (https=) | ||
| JP2020100630A5 (https=) | ||
| JP2022530042A5 (https=) | ||
| JP2024517204A5 (https=) | ||
| JP2019511506A5 (https=) | ||
| US20110257149A1 (en) | Formulation for oral transmucosal administration of lipid-lowering drugs | |
| CN1399544A (zh) | 以受控和脉动方式传递活性物质的多层制剂 | |
| EA016619B1 (ru) | Новые композиции на основе таксоидов | |
| KR20010102240A (ko) | 니코틴 의존증 치료를 위한 데옥시페가닌을 포함하는 약학조성물 | |
| EP3463298B1 (en) | Metronomic oral gemcitabine for cancer therapy | |
| EP0413694B1 (fr) | Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur | |
| AU2015260953B2 (en) | Pharmaceutical solution comprising dopamine for use in treating Parkinson's disease | |
| JP3022915B2 (ja) | 癌転移抑制剤 | |
| JP2016503406A5 (https=) | ||
| JP2022540917A5 (https=) | ||
| CN119770478B (zh) | 紫杉醇口服药物组合物、制剂及其制备方法和应用 |